Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect

Published 27/02/2024, 17:34
© Reuters.  Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect

Benzinga - by Piero Cingari, Benzinga Staff Writer.

Hedge funds are steering clear of the booming artificial intelligence (AI) market and other technology stocks that have led the market rally over the past year. Instead, they are placing their bets on the healthcare sector, revealing a calculated move towards stability and value.

According to the Goldman Sachs Hedge Funds Monitor, hedge funds are heavily favoring the healthcare sector, allocating to it over 600 basis points beyond the benchmark’s weight.

In the S&P 500, the healthcare sector boasts a 12.8% weight, while tech nearly 30%. For the median hedge fund portfolio as of the end of Q4 2023, healthcare a weight of nearly 20%, while tech was underweighted by six percentage points to about 24%.

Much of this overweight is likely due to the relatively underwhelming performance of healthcare stocks compared to technology, as well as their relative affordability.

The Technology Select Sector SPDR Fund (NYSE:XLK) has surged by nearly 50% in the past year. In contrast, healthcare stocks, as tracked by the Health Care Select Sector SPDR Fund (NYSE:XLV), have only risen by 13.7% over the same period.

From a valuation perspective, while the technology sector trades at about 28 times its forward one-year earnings, health care is relatively cheaper at 19 times forward earnings.

Delving deeper, hedge funds have placed their bets on a handful of conviction healthcare stocks. As of December, prominent names in their portfolios, include:

  • Eli Lilly & Company (NYSE:LLY)
  • Tenet Healthcare Corp. (NYSE:THC)
  • Karuna Therapeutics (NASDAQ:KRTX)
  • Boston Scientific Corp. (NYSE:BSX)
  • Danaher Corp (NYSE:DHR).
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Name ITMarket CapPrice Chg. % ↓ (YTD)
Eli Lilly and Company$ 694.85B32.42%
Catalent, Inc.$ 10.55B29.95%
Viatris Inc.$ 15.99B23.08%
Da Vita Inc.$ 11.10B20.87%
Merck & Co., Inc.$ 326.83B18.30%
GE HealthCare Technologies Inc.$ 10.55B18.04&
Striker Corp. $ 41.56B18.04%
HCA Health care$82.50B5.80%

Now Read: Ticking Time Bomb: Over 85% Of Americans Fear National Debt Crisis Impact On Their Future

Image: Shutterstock

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.